Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srinivas K Kumar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|April 20, 2005
Bis(carbamoyloxymethyl) esters of 2',3'-dideoxyuridine 5'-monophosphate (ddUMP) as potential ddUMP prodrugsSaeed R Khan, Srinivas K Kumar, David Farquhar
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2005
Sesquiterpenes: natural products that decrease cancer growthAneta Modzelewska, Surojit Sur, Srinivas K Kumar, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Design, synthesis and biological evaluation of novel riccardiphenol analogsSrinivas K Kumar, Maria Amador, Manuel Hidalgo, et al.
Journal of Medicinal Chemistry|June 27, 2003
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agentsSrinivas K Kumar, Erin Hager, Catherine Pettit, et al.
Bioorganic & Medicinal Chemistry|May 16, 2007
Modulating paclitaxel bioavailability for targeting prostate cancerSrinivas K Kumar, Simon A Williams, John T Isaacs, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancerSrinivas K Kumar, Indrajit Roy, Ravi K Anchoori, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|April 20, 2005
Bis(carbamoyloxymethyl) esters of 2',3'-dideoxyuridine 5'-monophosphate (ddUMP) as potential ddUMP prodrugsSaeed R Khan, Srinivas K Kumar, David Farquhar
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2005
Sesquiterpenes: natural products that decrease cancer growthAneta Modzelewska, Surojit Sur, Srinivas K Kumar, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Design, synthesis and biological evaluation of novel riccardiphenol analogsSrinivas K Kumar, Maria Amador, Manuel Hidalgo, et al.
Journal of Medicinal Chemistry|June 27, 2003
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agentsSrinivas K Kumar, Erin Hager, Catherine Pettit, et al.
Bioorganic & Medicinal Chemistry|May 16, 2007
Modulating paclitaxel bioavailability for targeting prostate cancerSrinivas K Kumar, Simon A Williams, John T Isaacs, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancerSrinivas K Kumar, Indrajit Roy, Ravi K Anchoori, et al.
Pageof 1